Adrian W Briggs

Interim Chief Executive Officer @Shape Therapeutics Inc

Seattle, WA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jun 2025 — Present

Interim Chief Executive Officer @Shape Therapeutics Inc

View department →

EDUCATION

2001 — 2004

University of Oxford

Bachelor of Arts - BA, Biological Sciences

2005 — 2010

Leipzig University

Doctor of Philosophy - PhD, Biochemistry

SKILLS

Cell CultureBioinformaticsCell BiologyImmunohistochemistryMicroscopyGenomicsSynthetic BiologyGeneticsDnaMolecular CloningMolecular BiologyFluorescence MicroscopyBiochemistryBiotechnologyProtein PurificationStem CellsDna Sequencing

ABOUT ADRIAN W BRIGGS

Molecular biology leader with a career focus on genetic technology, development of novel therapies and a background in human genetics.• Key founding member of the Nobel Prize-winning Neandertal Genome Project. • Leadership experience across five companies managing teams of PhD scientists in biotechnology R&D for diverse applications• Led engineered T-cell biology research through Celgene’s ~$9 billion acquisition of Juno and BMS\'~$74 billion acquisition of Celgene• Led the invention of “AbPair”, a single-cell sequencing technology that led to Juno’s purchase of AbVitro Inc. for ~$135 million• Oversaw discovery of multiple scFv and TCR molecules that are now lead candidates in BMS cell therapy programs• Success across diverse fields linked by high throughput sequencing and technology development• History of high impact scientific publications: 8 first-author papers with total 2,334 citations,>40 total publications with total 15,147 citations, h-index 30 (as of 11••••22, Google Scholar)Areas of Expertise Gene therapy - RNA editing - AAV engineering - DNA and RNA sequencing - Microfluidics - Single cell genetic analysis - Antibody & TCR discovery - Immunotherapy – Genome engineering - Ancient DNA – Human evolution – Population genetics

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.